Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Falciparum Malaria Vaccines
New falciparum malaria vaccines data have been reported by scientists at National Institute of Allergy and Infectious Disease
March 12th, 2008
A new study, 'Ex vivo cytokine and memory T cell responses to the 42-kDa fragment of Plasmodium falciparum merozoite surface protein-1 in vaccinated volunteers,' is now available. According to recent research from the United States, "A number of blood-stage malaria Ags are under development as vaccine candidates, but knowledge of the cellular responses to these vaccines in humans is limited. We evaluated the nature and specificity of cellular responses in healthy American volunteers vaccinated with a portion of the major merozoite surface protein-1 (MSP1) of Plasmodium falciparum, MSP1(42), formulated on Alhydrogel." "Volunteers were vaccinated three times with...
Source: Vaccine Weekly (2008-03-12)
|
